Client Communications - Prime Therapeutics

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Client Communication
Client Communications

Explore what's trending at Prime

https://www.primetherapeutics.com/w/white-house-announces-major-obesity-drug-pricing-shift-what-it-means-for-medicare-medicaid-and-trumprx Example Link

Client news

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

November 10, 2025

https://www.primetherapeutics.com/w/read-cms-balance-glp-1-model-notice-of-intent-due-jan.-8-1 Example Link

Client news

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

January 06, 2026

https://www.primetherapeutics.com/w/prime-teams-have-worked-diligently-to-prepare-for-peak-season-2026 Example Link

Client news

Prime teams have worked diligently to prepare for peak season 2026

December 29, 2026

https://www.primetherapeutics.com/w/read-white-house-expansion-and-upcoming-cms-drug-pricing-proposals Example Link

Client news

READ: White House expansion and upcoming CMS drug pricing proposals

December 29, 2026

The Latest

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/read-cms-balance-glp-1-model-notice-of-intent-due-jan.-8-1

Client news

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

January 06, 2026

https://www.primetherapeutics.com/w/prime-teams-have-worked-diligently-to-prepare-for-peak-season-2026

Client news

Prime teams have worked diligently to prepare for peak season 2026

December 29, 2026

https://www.primetherapeutics.com/w/read-white-house-expansion-and-upcoming-cms-drug-pricing-proposals

Client news

READ: White House expansion and upcoming CMS drug pricing proposals

December 29, 2026

https://www.primetherapeutics.com/w/read-update-on-prime-s-ncpdp-telecom/claims-f6-project

Client news

READ: Update on Prime's NCPDP telecom/claims F6 project

December 17, 2025

https://www.primetherapeutics.com/w/read-cms-releases-2027-negotiated-prices-for-15-medicare-part-d-drugs

Client news

READ: CMS releases 2027 negotiated prices for 15 Medicare Part D drugs

December 09, 2025

https://www.primetherapeutics.com/w/read-tariff-update-on-pharmaceuticals

Client news

READ: Tariff update on pharmaceuticals

December 03, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-december-2025-1

Client news

READ: Featured Drug Insights: December 2025

December 01, 2025

https://www.primetherapeutics.com/w/read-ira-faq-updates-november-2025

Client news

READ: IRA FAQ updates - November 2025

November 12, 2025

https://www.primetherapeutics.com/w/white-house-announces-major-obesity-drug-pricing-shift-what-it-means-for-medicare-medicaid-and-trumprx

Client news

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

November 10, 2025

Showing 1 to 9 of 143

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/read-cms-balance-glp-1-model-notice-of-intent-due-jan.-8-1

Client news

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

January 06, 2026

https://www.primetherapeutics.com/w/prime-teams-have-worked-diligently-to-prepare-for-peak-season-2026

Client news

Prime teams have worked diligently to prepare for peak season 2026

December 29, 2026

https://www.primetherapeutics.com/w/read-white-house-expansion-and-upcoming-cms-drug-pricing-proposals

Client news

READ: White House expansion and upcoming CMS drug pricing proposals

December 29, 2026

https://www.primetherapeutics.com/w/read-update-on-prime-s-ncpdp-telecom/claims-f6-project

Client news

READ: Update on Prime's NCPDP telecom/claims F6 project

December 17, 2025

https://www.primetherapeutics.com/w/read-tariff-update-on-pharmaceuticals

Client news

READ: Tariff update on pharmaceuticals

December 03, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-december-2025-1

Client news

READ: Featured Drug Insights: December 2025

December 01, 2025

https://www.primetherapeutics.com/w/white-house-announces-major-obesity-drug-pricing-shift-what-it-means-for-medicare-medicaid-and-trumprx

Client news

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

November 10, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-november-2025-1

Client news

READ: Featured Drug Insights: November 2025

November 10, 2025

https://www.primetherapeutics.com/w/read-fda-announces-major-biosimilar-policy-shift-prime-responds

Client news

READ: FDA announces major biosimilar policy shift – Prime responds

October 30, 2025

Showing 1 to 9 of 91

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/read-cms-balance-glp-1-model-notice-of-intent-due-jan.-8-1

Client news

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

January 06, 2026

https://www.primetherapeutics.com/w/prime-teams-have-worked-diligently-to-prepare-for-peak-season-2026

Client news

Prime teams have worked diligently to prepare for peak season 2026

December 29, 2026

https://www.primetherapeutics.com/w/read-white-house-expansion-and-upcoming-cms-drug-pricing-proposals

Client news

READ: White House expansion and upcoming CMS drug pricing proposals

December 29, 2026

https://www.primetherapeutics.com/w/read-update-on-prime-s-ncpdp-telecom/claims-f6-project

Client news

READ: Update on Prime's NCPDP telecom/claims F6 project

December 17, 2025

https://www.primetherapeutics.com/w/read-tariff-update-on-pharmaceuticals

Client news

READ: Tariff update on pharmaceuticals

December 03, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-december-2025-1

Client news

READ: Featured Drug Insights: December 2025

December 01, 2025

https://www.primetherapeutics.com/w/white-house-announces-major-obesity-drug-pricing-shift-what-it-means-for-medicare-medicaid-and-trumprx

Client news

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

November 10, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-november-2025-1

Client news

READ: Featured Drug Insights: November 2025

November 10, 2025

https://www.primetherapeutics.com/w/read-fda-announces-major-biosimilar-policy-shift-prime-responds

Client news

READ: FDA announces major biosimilar policy shift – Prime responds

October 30, 2025

Showing 1 to 9 of 105

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/read-cms-balance-glp-1-model-notice-of-intent-due-jan.-8-1

Client news

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

January 06, 2026

https://www.primetherapeutics.com/w/prime-teams-have-worked-diligently-to-prepare-for-peak-season-2026

Client news

Prime teams have worked diligently to prepare for peak season 2026

December 29, 2026

https://www.primetherapeutics.com/w/read-white-house-expansion-and-upcoming-cms-drug-pricing-proposals

Client news

READ: White House expansion and upcoming CMS drug pricing proposals

December 29, 2026

https://www.primetherapeutics.com/w/read-update-on-prime-s-ncpdp-telecom/claims-f6-project

Client news

READ: Update on Prime's NCPDP telecom/claims F6 project

December 17, 2025

https://www.primetherapeutics.com/w/read-tariff-update-on-pharmaceuticals

Client news

READ: Tariff update on pharmaceuticals

December 03, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-december-2025-1

Client news

READ: Featured Drug Insights: December 2025

December 01, 2025

https://www.primetherapeutics.com/w/white-house-announces-major-obesity-drug-pricing-shift-what-it-means-for-medicare-medicaid-and-trumprx

Client news

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

November 10, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-november-2025-1

Client news

READ: Featured Drug Insights: November 2025

November 10, 2025

https://www.primetherapeutics.com/w/read-fda-announces-major-biosimilar-policy-shift-prime-responds

Client news

READ: FDA announces major biosimilar policy shift – Prime responds

October 30, 2025

Showing 1 to 9 of 79

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/read-cms-balance-glp-1-model-notice-of-intent-due-jan.-8-1 Example Link

Client news

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

January 06, 2026

https://www.primetherapeutics.com/w/prime-teams-have-worked-diligently-to-prepare-for-peak-season-2026 Example Link

Client news

Prime teams have worked diligently to prepare for peak season 2026

December 29, 2026

https://www.primetherapeutics.com/w/read-white-house-expansion-and-upcoming-cms-drug-pricing-proposals Example Link

Client news

READ: White House expansion and upcoming CMS drug pricing proposals

December 29, 2026

https://www.primetherapeutics.com/w/read-update-on-prime-s-ncpdp-telecom/claims-f6-project Example Link

Client news

READ: Update on Prime's NCPDP telecom/claims F6 project

December 17, 2025

https://www.primetherapeutics.com/w/read-tariff-update-on-pharmaceuticals Example Link

Client news

READ: Tariff update on pharmaceuticals

December 03, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-december-2025-1 Example Link

Client news

READ: Featured Drug Insights: December 2025

December 01, 2025

https://www.primetherapeutics.com/w/white-house-announces-major-obesity-drug-pricing-shift-what-it-means-for-medicare-medicaid-and-trumprx Example Link

Client news

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

November 10, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-november-2025-1 Example Link

Client news

READ: Featured Drug Insights: November 2025

November 10, 2025

https://www.primetherapeutics.com/w/read-fda-announces-major-biosimilar-policy-shift-prime-responds Example Link

Client news

READ: FDA announces major biosimilar policy shift – Prime responds

October 30, 2025

Showing 1 to 9 of 86

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Read

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

Prime teams have worked diligently to prepare for peak season 2026

READ: White House expansion and upcoming CMS drug pricing proposals

The Latest

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

Prime teams have worked diligently to prepare for peak season 2026

READ: White House expansion and upcoming CMS drug pricing proposals

READ: Update on Prime's NCPDP telecom/claims F6 project

READ: CMS releases 2027 negotiated prices for 15 Medicare Part D drugs

READ: Tariff update on pharmaceuticals

READ: Featured Drug Insights: December 2025

READ: IRA FAQ updates - November 2025

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

Prime teams have worked diligently to prepare for peak season 2026

READ: White House expansion and upcoming CMS drug pricing proposals

READ: Update on Prime's NCPDP telecom/claims F6 project

READ: Tariff update on pharmaceuticals

READ: Featured Drug Insights: December 2025

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

READ: Featured Drug Insights: November 2025

READ: FDA announces major biosimilar policy shift – Prime responds

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

Prime teams have worked diligently to prepare for peak season 2026

READ: White House expansion and upcoming CMS drug pricing proposals

READ: Update on Prime's NCPDP telecom/claims F6 project

READ: Tariff update on pharmaceuticals

READ: Featured Drug Insights: December 2025

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

READ: Featured Drug Insights: November 2025

READ: FDA announces major biosimilar policy shift – Prime responds

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

Prime teams have worked diligently to prepare for peak season 2026

READ: White House expansion and upcoming CMS drug pricing proposals

READ: Update on Prime's NCPDP telecom/claims F6 project

READ: Tariff update on pharmaceuticals

READ: Featured Drug Insights: December 2025

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

READ: Featured Drug Insights: November 2025

READ: FDA announces major biosimilar policy shift – Prime responds

READ: CMS BALANCE GLP-1 Model — notice of intent due Jan. 8

Prime teams have worked diligently to prepare for peak season 2026

READ: White House expansion and upcoming CMS drug pricing proposals

READ: Update on Prime's NCPDP telecom/claims F6 project

READ: Tariff update on pharmaceuticals

READ: Featured Drug Insights: December 2025

READ: White House announces major obesity drug pricing shift: What it means for Medicare, Medicaid and TrumpRx

READ: Featured Drug Insights: November 2025

READ: FDA announces major biosimilar policy shift – Prime responds

Login Portals

Compliance / Legal

Company